{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:06:53Z","timestamp":1790856413386,"version":"4.1.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T00:00:00Z","timestamp":1601683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Serum human epididymis protein 4 (HE4) is associated with immune and inflammatory responses. This study aimed to assess the performance of serum HE4 in the early detection of cardiovascular (CV) events in patients with chronic obstructive pulmonary disease (COPD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Serum HE4 levels were measured in 199 patients with COPD, all of whom were prospectively followed up for a median period of 36 months (range\u2005=\u20053 months\u201338 months). Logistic regression analysis was performed to assess the association between cardiovascular disease (CVD) history and HE4 in patients with COPD. Cox proportional hazard analysis was performed to assess the prognostic value of serum HE4 for predicting CV events.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Serum HE4 levels were higher in patients with COPD with CV events than in those without CV events (252.6 pmol\/L [186.4\u2013366.8] vs 111.0 pmol\/L [84.8\u2013157.1]; P\u2005&amp;lt;.001). The multivariate logistic regression model revealed that serum HE4 (odds ratio\u2005=\u20051.639; 95% confidence interval [CI], 1.213\u20132.317; Ptrend\u2005=.009) was independently associated with CVD history after adjusting for age, sex, body mass index, current smoking status, current alcohol consumption status, admission systolic blood pressure and diastolic blood pressure, hyperlipidemia, left ventricular ejection fraction, primary diseases, and laboratory measurements in patients with COPD at baseline. The multivariate Cox proportional hazard analysis revealed that serum HE4 (hazard ratio\u2005=\u20052.012; 95% CI, 1.773\u20134.469; P\u2005&amp;lt;.001) was an independent prognostic factor for CV events in these patients. The Kaplan-Meier analysis showed that the rate of CV events was higher in patients with COPD with HE4 levels above the median (187.5 pmol\/L) than in those with HE4 levels below the median.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our results showed that serum HE4 was significantly and independently associated with CVD history and had independent predictive value for CV events in patients with COPD. Serum HE4 may enable early recognition of CV complication development among patients with COPD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/labmed\/lmaa076","type":"journal-article","created":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T19:14:53Z","timestamp":1598037293000},"page":"260-266","source":"Crossref","is-referenced-by-count":9,"title":["The Association Between Serum Human Epididymis Protein 4 Level and Cardiovascular Events in Patients with Chronic Obstructive Pulmonary Disease"],"prefix":"10.1093","volume":"52","author":[{"given":"Hui","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Mindong Hospital of Fujian Medical University, Fuan, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhong","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Mindong Hospital of Fujian Medical University, Fuan, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghua","family":"Su","sequence":"additional","affiliation":[{"name":"Neurosurgery Department, Mindong Hospital of Fujian Medical University, Fuan, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8657-4264","authenticated-orcid":false,"given":"Bin","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Mindong Hospital of Fujian Medical University, Fuan, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,10,3]]},"reference":[{"issue":"9","key":"2021050409523766800_CIT0001","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/thoraxjnl-2018-211553","article-title":"COPD and cardiovascular diseases: now is the time for action!","volume":"73","author":"Leitao","year":"2018","journal-title":"Thorax."},{"issue":"4","key":"2021050409523766800_CIT0002","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10654-010-9435-7","article-title":"Chronic obstructive pulmonary disease and the risk of cardiovascular diseases","volume":"25","author":"Schneider","year":"2010","journal-title":"Eur J Epidemiol."},{"issue":"2","key":"2021050409523766800_CIT0003","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1095\/biolreprod45.2.350","article-title":"A major human epididymis-specific cDNA encodes a protein with sequence homology to extracellular proteinase inhibitors","volume":"45","author":"Kirchhoff","year":"1991","journal-title":"Biol Reprod."},{"issue":"2","key":"2021050409523766800_CIT0004","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1530\/ror.0.0030086","article-title":"Molecular characterization of epididymal proteins","volume":"3","author":"Kirchhoff","year":"1998","journal-title":"Rev Reprod."},{"issue":"13","key":"2021050409523766800_CIT0005","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Hellstr\u00f6m","year":"2003","journal-title":"Cancer Res."},{"issue":"12","key":"2021050409523766800_CIT0006","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1515\/cclm-2012-0373","article-title":"HE4 in gynecological cancers: report of a European investigators and experts meeting","volume":"50","author":"Plebani","year":"2012","journal-title":"Clin Chem Lab Med."},{"issue":"12","key":"2021050409523766800_CIT0007","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1515\/cclm-2012-0097","article-title":"Human epididymis protein 4 (HE4) in benign and malignant diseases","volume":"50","author":"Hertlein","year":"2012","journal-title":"Clin Chem Lab Med."},{"issue":"6","key":"2021050409523766800_CIT0008","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol."},{"issue":"9","key":"2021050409523766800_CIT0009","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.it.2008.07.001","article-title":"Novel innate immune functions of the whey acidic protein family","volume":"29","author":"Bingle","year":"2008","journal-title":"Trends Immunol."},{"issue":"11","key":"2021050409523766800_CIT0010","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1373\/clinchem.2010.157073","article-title":"Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases","volume":"57","author":"Escudero","year":"2011","journal-title":"Clin Chem."},{"issue":"6","key":"2021050409523766800_CIT0011","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1158\/0008-5472.CAN-04-3924","article-title":"Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas","volume":"65","author":"Drapkin","year":"2005","journal-title":"Cancer Res."},{"issue":"1","key":"2021050409523766800_CIT0012","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40169-015-0068-z","article-title":"Inflammation in chronic obstructive pulmonary disease and its role in cardiovascular disease and lung cancer","volume":"4","author":"King","year":"2015","journal-title":"Clin Transl Med."},{"key":"2021050409523766800_CIT0013","doi-asserted-by":"crossref","first-page":"S2155","DOI":"10.21037\/jtd.2019.10.54","article-title":"Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis","volume":"11","author":"Parris","year":"2019","journal-title":"J Thorac Dis."},{"issue":"1","key":"2021050409523766800_CIT0014","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cardfail.2016.05.002","article-title":"HE4 serum levels are associated with heart failure severity in patients with chronic heart failure","volume":"23","author":"Piek","year":"2017","journal-title":"J Card Fail."},{"issue":"2","key":"2021050409523766800_CIT0015","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jchf.2012.11.005","article-title":"The WAP four-disulfide core domain protein HE4: a novel biomarker for heart failure","volume":"1","author":"de Boer","year":"2013","journal-title":"JACC Heart Fail."},{"issue":"2","key":"2021050409523766800_CIT0016","first-page":"169","article-title":"Human epididymis protein 4 as an indicator of acute heart failure in patients with chronic kidney disease","volume":"51","author":"Huang","year":"2020","journal-title":"Lab Med."},{"issue":"3","key":"2021050409523766800_CIT0017","first-page":"653","article-title":"Evaluation of individuals at risk for COPD: beyond the scope of the Global Initiative for Chronic Obstructive Lung Disease","volume":"3","author":"Antuni","year":"2016","journal-title":"Chronic Obstr Pulm Dis."},{"issue":"9","key":"2021050409523766800_CIT0018","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med."},{"issue":"9859","key":"2021050409523766800_CIT0019","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet."},{"issue":"4","key":"2021050409523766800_CIT0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1378\/chest.12-2847","article-title":"Cardiovascular comorbidity in COPD: systematic literature review","volume":"144","author":"M\u00fcllerova","year":"2013","journal-title":"Chest."},{"issue":"3","key":"2021050409523766800_CIT0021","doi-asserted-by":"crossref","first-page":"15015","DOI":"10.1038\/nrdp.2015.15","article-title":"Obstructive sleep apnoea syndrome","volume":"1","author":"L\u00e9vy","year":"2015","journal-title":"Nat Rev Dis Primers."},{"issue":"2","key":"2021050409523766800_CIT0022","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jjcc.2017.03.001","article-title":"Total management of chronic obstructive pulmonary disease (COPD) as an independent risk factor for cardiovascular disease","volume":"70","author":"Onishi","year":"2017","journal-title":"J Cardiol."},{"issue":"4","key":"2021050409523766800_CIT0023","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1177\/1933719113503416","article-title":"Human epididymis protein 4 and secretory leukocyte protease inhibitor in vaginal fluid: relation to vaginal components and bacterial composition","volume":"21","author":"Orfanelli","year":"2014","journal-title":"Reprod Sci."},{"issue":"3","key":"2021050409523766800_CIT0024","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung","volume":"7","author":"Bingle","year":"2006","journal-title":"Respir Res."},{"issue":"2","key":"2021050409523766800_CIT0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nm.2989","article-title":"Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis","volume":"19","author":"LeBleu","year":"2013","journal-title":"Nat Med."},{"issue":"3","key":"2021050409523766800_CIT0026","first-page":"124","article-title":"Fibrosis: HE4\u2013a biomarker and target in renal fibrosis","volume":"9","author":"Allison","year":"2013","journal-title":"Nat Rev Nephrol."}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/labmed\/article-pdf\/52\/3\/260\/37776582\/lmaa076.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/labmed\/article-pdf\/52\/3\/260\/37776582\/lmaa076.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T09:54:03Z","timestamp":1620122043000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/labmed\/article\/52\/3\/260\/5917570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,3]]},"references-count":26,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,10,3]]},"published-print":{"date-parts":[[2021,5,4]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmaa076","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5,1]]},"published":{"date-parts":[[2020,10,3]]}}}